Exit of platelet glycoprotein-IIb/IIIa-receptor inhibitors?
Verstraete
M
M
D000284:Administration, Oral; D001161:Arteriosclerosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D007262:Infusions, Intravenous; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*
D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex